ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,074Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 6969

$898K Total Retail Price of All Prescriptions

Rank: 170 out of 6969

882 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 882 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

21% of this provider’s 882 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 16,187 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 1,285 1,129 1 1
HYDROCODONE-ACETAMINOPHEN 846 658 S3 2 3
METFORMIN HCL 788 670 3 7
LEVOTHYROXINE SODIUM 714 614 4 5
OMEPRAZOLE 648 573 5 6
LISINOPRIL 621 555 6 2
CITALOPRAM HBR 461 381 7 34
DOXAZOSIN MESYLATE 393 346 8 74
FUROSEMIDE 388 356 9 10
ATENOLOL 350 299 10 9
ALENDRONATE SODIUM 328 308 11 14
DOXYCYCLINE HYCLATE 317 281 12 158
IBUPROFEN 293 259 13 29
RANITIDINE HCL 290 243 14 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 280 219 15 28
FENOFIBRATE 280 199 15 63
LOVASTATIN 263 262 17 15
GLIPIZIDE 245 212 18 21
HYDROCHLOROTHIAZIDE 231 217 19 8
METOPROLOL TARTRATE 218 201 20 13
NAMENDA 214 203 21 51
ATORVASTATIN CALCIUM 196 176 22 11
LORAZEPAM 195 177 23 186
CIPROFLOXACIN HCL 180 155 24 64
GABAPENTIN 178 149 25 17
AMLODIPINE BESYLATE 174 149 26 4
BENAZEPRIL HCL 173 138 27 18
DONEPEZIL HCL 171 171 28 32
PREDNISONE 164 154 29 70
LOSARTAN POTASSIUM 161 157 30 12
ZOLPIDEM TARTRATE 158 115 31 16
LOSARTAN-HYDROCHLOROTHIAZIDE 143 122 32 53
ADVAIR DISKUS 129 127 33 45
JANUVIA 124 101 34 41
SULFAMETHOXAZOLE-TRIMETHOPRIM 122 104 35 114
ALBUTEROL SULFATE 121 119 36 123
OXYBUTYNIN CHLORIDE 121 93 36 126
PROAIR HFA 118 113 38 33
BETAMETHASONE DIPROPIONATE 117 113 39 250
ALPRAZOLAM 116 82 40 172
CEPHALEXIN 116 106 40 96
FLUTICASONE PROPIONATE 111 102 42 24
CARVEDILOL 108 99 43 25
FINASTERIDE 106 90 44 80
TIZANIDINE HCL 104 90 45 298
LIPITOR 104 87 45 89
NAPROXEN 101 88 47 62
LANTUS 100 81 48 50
SPIRIVA 100 100 48 66
ISOSORBIDE MONONITRATE ER 97 97 50 81
INSULIN SYRINGE 95 60 51 60
TERAZOSIN HCL 91 88 52 49
METOCLOPRAMIDE HCL 90 55 53 136
CLOPIDOGREL 89 88 54 48
ALLOPURINOL 88 84 55 35
FLUOXETINE HCL 84 54 56 43
DIGOXIN 84 69 56 71
POTASSIUM CHLORIDE 83 54 58 30
DILTIAZEM 24HR ER 82 81 59 183
POLYETHYLENE GLYCOL 3350 81 69 60 127
QUINAPRIL HCL 78 69 61 239
PLAVIX 77 76 62 68
TERBINAFINE HCL 75 67 63 427
NYSTATIN-TRIAMCINOLONE 74 69 64 278
WARFARIN SODIUM 73 63 65 20
TRAMADOL HCL 72 69 66 27
ENALAPRIL MALEATE 70 70 67 56
TRAZODONE HCL 69 43 68 47
NIFEDIPINE ER 68 68 69 95
HUMALOG 65 49 70 167
VENLAFAXINE HCL ER 65 44 70 150
BACLOFEN 63 0 72 86
RISPERIDONE 63 27 72 88
AMITRIPTYLINE HCL 63 37 R 72 87
GLYBURIDE 62 45 R 75 54
CARTIA XT 62 50 75 458
BENAZEPRIL-HYDROCHLOROTHIAZIDE 59 52 77 132
PAROXETINE HCL 55 26 78 65
CAPTOPRIL 50 50 79 226
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.